metformin has been researched along with allylamine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bays, HE; Goldberg, RB; Jones, MR; Truitt, KE | 1 |
| Abby, SL; Jones, MR; Rosenson, RS | 1 |
| Abby, SL; Jialal, I; Misir, S; Nagendran, S | 1 |
| Abby, SL; Hernandez-Triana, E; Jin, X; Jones, MR; Lai, YL; Misir, S; Mudaliar, S; Nagendran, S; Unnikrishnan, AG | 1 |
| Hagan, MA; Simons, WR | 1 |
| Handelsman, Y; Hernandez-Triana, E; Jones, MR; Misir, S; Nagendran, S; Rosenstock, J | 1 |
| Garg, SK; Michels, AW; Shah, VN | 1 |
1 review(s) available for metformin and allylamine
| Article | Year |
|---|---|
Use of non-insulin therapies for type 1 diabetes.
Topics: Allylamine; Animals; Blood Glucose; Bromocriptine; Cardiovascular Diseases; Colesevelam Hydrochloride; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Gastrins; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Islet Amyloid Polypeptide; Leptin; Metformin; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiazolidinediones; United States | 2013 |
5 trial(s) available for metformin and allylamine
| Article | Year |
|---|---|
Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.
Topics: Adolescent; Adult; Aged; Allylamine; Anticholesteremic Agents; Blood Glucose; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Retrospective Studies; Treatment Outcome | 2008 |
Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes.
Topics: Aged; Allylamine; Anticholesteremic Agents; Biomarkers; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipoproteins; Magnetic Resonance Spectroscopy; Male; Metformin; Middle Aged; Particle Size; Sulfonylurea Compounds; Time Factors; Treatment Outcome | 2009 |
Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis.
Topics: Aged; Allylamine; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Sulfonylurea Compounds | 2009 |
Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes.
Topics: Adolescent; Adult; Aged; Algorithms; Allylamine; Anticholesteremic Agents; Clinical Trials as Topic; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Placebos; Prediabetic State; Research Design; Young Adult | 2009 |
Initial combination therapy with metformin plus colesevelam in drug-naïve Hispanic patients with early type 2 diabetes.
Topics: Allylamine; Anticholesteremic Agents; Cholesterol; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Hispanic or Latino; Humans; Hypoglycemic Agents; Lipoproteins; Male; Metformin; Treatment Outcome | 2012 |
1 other study(ies) available for metformin and allylamine
| Article | Year |
|---|---|
An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
Topics: Adult; Aged; Allylamine; Cardiovascular Diseases; Cholesterol, LDL; Colesevelam Hydrochloride; Cost-Benefit Analysis; Databases, Factual; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Health Care Costs; Humans; Hypercholesterolemia; Insulin; Male; Metformin; Middle Aged; Models, Economic; Randomized Controlled Trials as Topic; Risk; Sulfonylurea Compounds; Treatment Outcome; United States | 2010 |